GIVAUDAN N/ CH0010645932 /
| 6/13/2025 5:31:20 PM | Chg. -47.00 | Volume | Bid7:04:29 PM | Ask7:04:29 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 4,124.00CHF | -1.13% | 12,547 Turnover: 51.81 mill. |
4,100.00Bid Size: 18 | 4,161.00Ask Size: 20 | 38.08 bill.CHF | 1.70% | 34.90 |
Business description
Givaudan is a global leading company in taste and wellbeing, and fragrance and beauty. With its heritage stretching back over 250 years, the Company has a long history of innovating scents and tastes. From a favourite drink to your daily meal, from prestige perfumes to cosmetics and laundry care, its creations inspire emotions and delight millions of consumers the world over. The Company is committed to driving purpose-led, long-term growth while leading the way to improve happiness and health for people and nature.
Management board & Supervisory board
| CEO |
|---|
| Gilles Andrier |
| Management board |
| Stewart Harris, Louie D’Amico, Maurizio Volpi, Anne Tayac, Simon Halle-Smith, Willem Mutsaerts |
| Supervisory board |
| Calvin Grieder, Ingrid Deltenre, Melanie Maas-Brunner, Victor Balli, Sophie Gasperment, Roberto Guidetti, Tom Knutzen |
Company data
| Name: | Givaudan SA |
| Address: | 5, Chemin de la Parfumerie,Vernier |
| Phone: | +41-22-780-9111 |
| Fax: | +41-22-780-9150 |
| E-mail: | global.recruitment@...dan.com global.recruitment@givaudan.com |
| Internet: | www.givaudan.com |
| Industry: | Commodities |
| Sector: | Chemicals |
| Sub sector: | Chemicals, Specialty |
| End of financial year: | 12/31 |
| Free Float: | 99.78% |
| IPO date: | 6/8/2000 |
Investor relations
| Name: | Claudia Pedretti |
| IR phone: | +41 22 7809111 |
| IR Fax: | +41-22-780-9090 |
| IR e-mail: | givaudan.investors@g...dan.com givaudan.investors@givaudan.com |
Company calendar
| CW 30 | 7/22/2025 Interim Report 2nd Quarter/6 Months |
| CW 42 | 10/14/2025 Interim Report 3rd Quarter/9 Months |
Main Shareholders
| Others | 72.28% | |
| William H. Gates III | 12.03% | |
| UBS Fund Management (Switzerland) AG | 5.67% | |
| BlackRock, Inc. | 5.06% | |
| Haldor Foundation | 4.96% |
